×

Signature Event: Long Covid: Research, Policy and Economic Impact

Date: Thursday, May 19, 2022
New York City, NY

$25.00$100.00

The Global Interdependence Center – Solve Long Covid Initiative Program Series continues with our signature event on May 19, 2022. 

Registration is currently not available for this event.

SKU: N/A

Event Detail

Signature Event: Long Covid: Research, Policy and Economic Impact

The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is continuing our conference series exploring the pandemic’s long-term healthcare, policy, and economic impact, specifically the implications of long haul COVID or long COVID. Together, we invite you to join us for the signature event of this series, an in-person conference in New York City on Thursday, May 19, 2022.

The purpose of our conference is to raise awareness of Long Covid by examining the science and research behind it and we hope can join us through one of our registration options, including in-person or virtual attendance. For those joining us in person, we are delighted to provide a Patient Rest Area on site at the event. This quiet space will be a rest area for patients who need to step away for flare-up/sensory overload equipped with cots/chairs/blankets.

 

Continuing Education: Please email [email protected] for more information on how attendees of this event can receive continuing education credit from the CFP Board for 3 CE credit hours.

 

Agenda

8:00 a.m. | Registration and Continental Breakfast

9:00 a.m. | Welcome Remarks

  • Oved Amitay, Chief Executive Officer at Solve M.E.
  • Bill Kennedy, GIC Chair and Co-Founder, CEO and CIO of RiskBridge Advisors

9:15 a.m. | Session I: Scientific Research

  • Bruce Patterson, MD, CEO and founder of IncellDx Inc.
  • Marjan Islam, MD, Assistant Professor of Medicine in the Division of Pulmonary Medicine at Albert Einstein College of Medicine and Montefiore Medical Center
  • Moderator: Kate Mudie, Research Senior Manager, Solve M.E.

10:30 a.m. | Session II: Industry-Specific Implications

  • Clinical care and NIH’s RECOVER Study
    • Leora Horwitz, M.D., MHS, Director of the Center for Healthcare Innovation and Delivery Science, New York University – Langone Health
  • Health Insurance
    • Nalini Raju, M.D. Senior Medical Director of CIGNA
  • Pharmaceuticals
    • Thomas Equels, M.S., J.D., Chief Executive Officer of Aim Immunotech – Amplegin/Clinical Trials for Long Covid
    • Rich Moscicki, Chief Medical Officer of PhRMA
  • Legal Outlook
    • Barbara B. Comerford, Founder of the Law Offices of Barbara B. Comerford
  • Moderator: Oved Amitay, Chief Executive Officer at Solve M.E.

11:45 a.m. – 12:00 p.m. | Break

12:00 p.m. | Solve Long Covid Initiative Publication Material Announcement and Special Report

  • Oved Amitay, Chief Executive Officer at Solve M.E.
  • Melissa Smallwood, Co-Author: Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost

12:15 p.m. | Keynote: Vaccinating vs. Long Covid

  • Dr. Peter Hotez and Dr. Maria Elena Bottazzi, Deans of the National School of Tropical Medicine at Baylor College of Medicine and Co-Directors of the Center for Vaccine Development at Texas Children’s Hospital
    Dr. Peter Hotez and Dr. Maria Elena Bottazzi are nominees for the 2022 Nobel Peace Prize for their work to develop and distribute a low-cost COVID-19 vaccine to people of the world without patent limitation. 
  • Q&A with David Kotok, GIC Board Member and Chief Investment Officer of Cumberland Advisors

1:00 – 2:15 p.m. | Lunch

2:15 p.m. | Session III:  Economic Impact and Labor Market Challenges

  • Philippa Dunne, Co-Editor, The Liscio Report and Sightlines Bulletin
  • Holly Wade, GIC Board Member and Executive Director, National Federation of Independent Business (NFIB) Research Center
  • Dana Peterson, GIC Board Member and Chief Economist & Center Leader of Economy, Strategy & Finance at The Conference Board
  • Moderator: Kathleen Stephansen, GIC Chair Emeritus

3:30 p.m. | Session IV:  The Human Experience

  • Elle Seibert, Registry Data Manager, Solve M.E. & Long COVID patient
  • Susan Levine, MD, ME/CFS and Long COVID specialist, former chair of the CFS Federal Advisory Committee
  • Lauren Nichols, Vice President, Body Politic
  • Moderator: Emily Taylor, Vice President of Advocacy and Community Relations, Solve Long Covid Initiative/Solve M.E. and Co-Author: Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost

4:30 p.m. | Concluding Remarks

  • Bill Kennedy, GIC Chair and Co-Founder, CEO and CIO of RiskBridge Advisors

 

 

COVID-19 Protocols

Masks are mandatory. Registrants must be fully vaccinated and show proof of vaccination upon arrival. Please do not attend if you have any COVID or flu like symptoms.

 

The New York Athletic Club Dress Code

  • Gentlemen – Jackets are optional in most areas. Slacks, a collared shirt and dress shoes are permitted. Shirts must be tucked in. Jackets are required in the Main Dining Room and Cocktail Lounge.
  • Ladies – Permitted attire refers to business suits, tailored pant or skirt ensembles, and dresses. Spandex, open midriffs, halter tops, leggings, denim and extremely short hemlines (more than 3″ above the knee, as a guideline) are not permitted.
  • Jeans, T-shirts, sneakers and flip-flops are prohibited. Attire with rips, frays or tears or that displays language, motifs or insignias that may be deemed offensive are not permitted. 

 


About the David R. Kotok Global Healthcare Series

GIC launched the David R. Kotok Global Healthcare Series in 2020; a virtual program series focused on the roles health and healthcare policy play in the interdependent global community.  As a part of the series, the GIC has launched the “Analyzing Pandemics: Economic and Policy Impacts” executive briefings to explore the 100-year global pandemic event. Past briefings focused on the disease and the cure, COVID-19’s impact on food supply chains, artificial intelligence, climate change, and higher education.

In 2021, David Kotok and the Solve Long COVID Initiative offered a new gift to the GIC for funding, sponsorship, and logistical support for the Long COVID Program Series. The series serves as a neutral forum to elevate, vet, and share information about changing interdependencies caused by Long COVID’s impact on medical research, health care policy, fiscal policy, monetary policy, finance, trade, politics, and culture.

About the Solve Long Covid Initiative  

The Solve Long Covid Initiative represents a collection of new and expanded programs in research, advocacy, and education that will improve outcomes for the millions suffering from post-infection diseases. Based on more than 30 years of research and advocacy experience advancing the understanding of post-infection diseases, the Solve Long Covid Initiative takes a strategic approach to integrating pre-pandemic and post-pandemic knowledge and community insights. Our work in the post-infection disease space has allowed us to create connections and build partnerships with researchers, clinicians, patients, government, and industry leaders.

Event Location

Date: Thursday, May 19, 2022 Time: 8:00 AM - 5:00 PM

Event Venue:
The New York Athletic Club
180 Central Park South
New York, NY 10019

Download iCal

Speakers

Oved Amitay

Oved Amitay

Chief Executive Officer at Solve M.E.

Oved Amitay is the Chief Executive Officer at Solve M.E. He has dedicated most of his professional career to the development of life-changing therapeutic options for people affected by rare genetic diseases.

Read More

Maria Elena Bottazzi, Ph.D.

Maria Elena Bottazzi, Ph.D.

Dean of the National School of Tropical Medicine at Baylor College of Medicine and Co-Director of the Center for Vaccine Development at Texas Children’s Hospital

Maria Elena Bottazzi, is Associate Dean of the National School of Tropical Medicine, Professor of Pediatrics, Molecular Virology & Microbiology, Division Chief of Pediatric Tropical Medicine and Co-director of Texas Children’s Center for Vaccine Development at Baylor College of Medicine in Houston and Distinguished Professor in Biology at Baylor University in Waco.

Read More

Barbara B. Comerford

Barbara B. Comerford

Founder of the Law Offices of Barbara B. Comerford

Barbara B. Comerford has been practicing disability law in Bergen County, New Jersey for over 30 years primarily in the area of ERISA long-term disability insurance claims and litigation; and Social Security Disability claims and litigation.

Read More

Philippa Dunne

Philippa Dunne

Co-Editor, The Liscio Report and Sightlines Bulletin

Philippa Dunne is co-editor of two independent macro-economic newsletters: The Liscio Report, with a trading focus, and Sightlines Bulletin, which takes a longer perspective.

Read More

Thomas K. Equels, M.S., J.D.

Thomas K. Equels, M.S., J.D.

CEO, Aim Immunotech

Thomas Equels, M.S., J.D. was named Chief Executive Officer of Aim Immunotech in February 2016 and has served as President since August 2015. Equels’ successful legal career included extensive experience in the pharma sector.

Read More

Peter J. Hotez, M.D., Ph.D.

Peter J. Hotez, M.D., Ph.D.

Dean of the National School of Tropical Medicine at Baylor College of Medicine and Co-Director of the Center for Vaccine Development at Texas Children’s Hospital

Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also the Co-director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. 

Read More

Leora Horwitz, MD, MHS

Leora Horwitz, MD, MHS

Director, Center for Healthcare Innovation and Delivery Science, NYU Langone Health

Dr. Horwitz is director of the Center for Healthcare Innovation and Delivery Science at NYU Langone Health, director of the Division of Healthcare Delivery Science in the Department of Population Health at NYU School of Medicine, tenured professor of population health and of medicine, and a practicing internist.

Read More

Marjan Islam, MD

Marjan Islam, MD

Assistant Professor of Medicine in the Division of Pulmonary Medicine at Albert Einstein College of Medicine and Montefiore Medical Center

Dr. Marjan Islam is an Assistant Professor of Medicine in the Division of Pulmonary Medicine at Albert Einstein College of Medicine and Montefiore Medical Center. Dr. Islam received his medical degree from Stony Brook University School of Medicine. He completed residency in Internal Medicine at Mount Sinai Beth Israel and completed fellowship in Pulmonary and Critical Care Medicine at Montefiore Medical Center, where he served as Chief Fellow.

Read More

William Kennedy, CFA

William Kennedy, CFA

Board Chair, Global Interdependence Center CEO, Chief Investment Officer, RiskBridge Advisors, LLC

William Kennedy is the co-founder, CEO, and Chief Investment Officer of RiskBridge Advisors, an independent, full-service investment office serving insurers, endowments and foundations, and individual investors. He is responsible for RiskBridge’s business and investment activities and has over 30 years of capital market research and investment experience.

Read More

David Kotok

David Kotok

Chief Investment Officer of Cumberland Advisors

David Kotok co-founded Cumberland Advisors in 1973 and has been its Chief Investment Officer since inception. David’s articles and financial market commentaries have appeared in the New York Times, the Wall Street Journal, Barron’s, and other publications. He is a frequent contributor to Bloomberg TV and Bloomberg Radio, Yahoo Finance TV, and other media.

Read More

Susan M. Levine, M.D.

Susan M. Levine, M.D.

ME/CFS and Long COVID specialist, former chair of the CFS Federal Advisory Committee

Susan M. Levine, M.D., graduated from Albert Einstein School of Medicine in 1981 and completed a residency in Internal Medicine at Montefiore Hospital in the Bronx followed by two fellowships in Infectious Diseases and Allergy and Immunology at Memorial Sloan Kettering Cancer Center and Mt. Sinai Hospital, respectively. 

Read More

Rich A. Moscicki, M.D.

Rich A. Moscicki, M.D.

Executive Vice President for Science and Regulatory Advocacy and Chief Medical Officer of PhRMA

Richard (Rich) A. Moscicki (Mo-shis-ke), M.D., is the Executive Vice President for Science and Regulatory Advocacy and the Chief Medical Officer at Pharmaceutical Research and Manufacturers of America (PhRMA).

Read More

Kate Mudie

Kate Mudie

Research Senior Manager, Solve M.E.

Kate Mudie is the Research Senior Manager at Solve M.E. where her responsibilities include coordination of the registry and biobank, oversight of data and analyses, and management of the Ramsay Grant Program.

Read More

Lauren Nichols

Lauren Nichols

Vice President of Body Politic

Lauren Nichols is the Vice President of Body Politic, a patient-led health justice organization at the forefront of the Long COVID movement, the home of the first COVID-19 Support Group, and the first entity to research Long COVID.

Read More

Bruce Patterson, MD

Bruce Patterson, MD

CEO and founder of IncellDx Inc.

Bruce Patterson, MD received his undergraduate training in molecular biology from the University of Michigan in Ann Arbor. He then received his MD at Northwestern University Feinberg School of Medicine followed by a residency in pathology.

Read More

Dana Peterson

Dana Peterson

Chief Economist & Center Leader of Economy, Strategy & Finance at The Conference Board

Dana Peterson is the Chief Economist & Center Leader of Economy, Strategy & Finance at The Conference Board. Peterson joins The Conference Board from Citi, where for many years she served as a North America Economist and later as a Global Economist. Her wealth of experience extends to the public sector, having also worked at the Federal Reserve Board in Washington, D.C.

Read More

Nalini Raju, M.D., M.P.H., M.B.A

Nalini Raju, M.D., M.P.H., M.B.A

Senior Medical Director, Cigna

Dr. Raju is a Senior Medical Director at Cigna. As Cigna's COVID Medical Director, she works closely with key matrix partners across the enterprise to coordinate Cigna's COVID response. Her efforts have been focused on improving clinical outcomes and quality.

Read More

Elle Seibert

Elle Seibert

Registry Data Manager of You + ME Registry at Solve M.E.

Elle Seibert is the Registry Data Manager at the You + ME Registry, an online clinical study of ME/CFS, Long COVID + other post-viral illnesses. Since joining Solve M.E., Elle has cultivated relationships with key stakeholders in the ME/CFS and Long-COVID space, with the understanding that thoughtful community engagement yields better research. By maintaining a presence in these communities, Elle has come to recognize post-viral illness as a social-scientific issue, rather than a purely medical phenomenon.

Read More

Melissa Smallwood

Melissa Smallwood

Co-Author: Long Covid Impact on Adult Americans: Early Indicators Estimating Prevalence and Cost

Melissa Smallwood (MS 2021, MA 2016) is a Science and Technology Policy researcher with a background in neuroscience, psychology, social science, and disability studies. She is a recent graduate of Arizona State University's School for the Future of Innovation in Society, where she worked on her Master's Thesis with Brian David Johnson's Threatcasting lab.

Read More

Kathleen Stephansen

Kathleen Stephansen

GIC Chair Emeritus, Senior Economist for Haver Analytics and Trustee of EQAT Trust Funds

Kathleen Stephansen is GIC Chair Emeritus, Senior Economist for Haver Analytics and Trustee of EQAT Trust Funds. She is the former Chief Economist of Huawei Technologies, Chief Economist of the American International Group (AIG) and AIG Asset Management’s Senior Strategist and Global Head of Sovereign Research. Prior to joining AIG in 2010, Kathleen was Chief Economist at Aladdin Capital Holdings, Credit Suisse’s Head of Global Economic Research, and Donaldson, Lufkin and Jenrette Securities Corporation’s co-head of Fixed Income economic research and Chief International Economist.

Read More

Emily Taylor

Emily Taylor

Vice President of Advocacy and Engagement, Solve M.E.

Emily Taylor is the Director of Advocacy and Engagement for Solve M.E. She brings to the organization over fifteen years of policy, organization, and advocacy experience in both the non-profit and government sectors.

Read More

Holly Wade

Holly Wade

Executive Director of the NFIB Research Center

Holly Wade is the executive director of the NFIB Research Center, where she conducts original research and studies public policy effects on small businesses. She produces NFIB’s monthly Small Business Economic Trends survey and surveys on topics related to small business operations.

Read More

Partners

Solve Long COVID Initiative

Sponsors

Responsum for Long Covid